Acute Lung Injury clinical trials at UCSF
1 research study open to eligible people
Acute lung injury happens when the lungs get badly hurt. UCSF is running studies to see if stem cells can make the lungs better. These trials are looking for patients who have serious lung issues.
Showing trials for
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
open to eligible people ages 18-75
To evaluate the safety and efficacy of intravenous (IV) administration of bone marrow mesenchymal stem cell derived extracellular vesicles (EVs), ExoFlo, versus placebo for the treatment of hospitalized patients with moderate-to-severe Acute Respiratory Distress Syndrome (ARDS).
San Francisco, California and other locations